Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cryocompression for Bortezomib-Induced Peripheral Neuropathy Among Multiple Myeloma Patients

NCT03870451 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT03870451
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03870451 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cryocompression for Bortezomib-Induced Peripheral Neuropathy Among Multiple Myeloma Patients
Lead sponsor
Wake Forest University Health Sciences
Phase
Not applicable
Overall status
Terminated
Start date
November 1, 2019
Completion date
February 10, 2023
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced peripheral neuropathy, plasma cell myeloma